FDA Must Make it Clear Abortion Pills are Dangerous for Women

FDA Commissioner Marty Makary has recently promised to undertake a new review of the “postmarketing safety data on mifepristone for the medical termination of early pregnancy.”In an open letter to the Commissioner, Elliot Institute director David Reardon, has asked Makary to also direct the FDA to require the abortion pill makers to provide the post-abortion follow-up data necessary to develop evidence-based benefit-risk assessments.Get the latest pro-life news and information on X (Twitter). Fo